Management of Ardhavbhedaka (Migraine) with Shirodhara and through Nasal Administration Procedure

A Clinical Study of "Gunja Taila Nasya" and "Dashmoola Shrit Ksheera Shirodhara" in the Management of Ardhavbhedaka (Migraine)

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045891

Enrollment

Registered

2022-09-26

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed and confirmed cases of ardhavabhedaka (migraine) according to CRF. 2.Clinically Fit for Nasya Karma and Shirodhara. 3.Patients willing to give written consent.

Exclusion criteria

Exclusion criteria: 1.Patients who were suffering from secondary headaches like meningitis, brain tumor, encephalitis, cervical spondylitis, sinus, refractive errors & glaucoma. 2.Patients who were suffering from chronic disease like hypertension, COPD, renal disease etc. 3.Pregnant and lactating women. 4.A Patient of Ardhavbhedaka who was taking other treatment was excluded.

Design outcomes

Primary

Measure	Time frame
Subjective Criteria Based On Symptoms Of Disease Objective Criteria Midas (Migraine Disability Assessment Test) Visual Analogue Score (Vas) Timepoint: 4 weeks	—

Secondary

Measure	Time frame
To find out the comperative efficacy of the treatment in both groups With the help of MIDAS (Migraine Disability Assessment Test), VISUAL ANALOGUE SCORE (VAS) and Symptoms of DiseaseTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Madhu

Upgiasr Dsrrau

atreyagyan@gmail.com9829798701

Outcome results